Circulating anti-brain autoantibodies in schizophrenia and mood disorders

Psychiatry Research

Volumn 230, Issue 2, 2015, Pages 704-708

  Margari, Francesco ^a   Petruzzelli, Maria Giuseppina ^a   Mianulli, Rossana ^a   Campa, Maria Gloria ^a   Pastore, Adriana ^a   Tampoia, Marilina ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

ANA; Autoimmunity; Cerebellum; Hippocampus; Hypothalamus; Psychiatric disorders

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ANIMAL; AUTOIMMUNITY; BLOOD; BRAIN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOOD DISORDERS; PHYSIOLOGY; RAT; SCHIZOPHRENIA;

ADULT; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BIOMARKERS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; RATS; SCHIZOPHRENIA;

EID: 84947080482     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.10.029     Document Type: Article

References (36)

1. Appleby B. Are anti-nuclear antibodies common in affective disorders? A review of the past 35 years. Psychosomatics 2007, 48:286-289.
2. Benros M.E., Nielsen P.R., Nordentoft M., Eaton W.W., Dalton S.O., Mortensen P.B. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am. J. Psychiatry 2011, 168:1303-1310.
3. Bergink V., Gibney S.M., Drexhage H.A. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol. Psychiatry 2014, 75:324-331.
4. Bilbo S.D., Schwarz J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocr. 2012, 33:267-286.
5. Carter C.S., Bullmore E.T., Harrison P. Is there a flame in the brain in psychosis?. Biol. Psychiatry 2014, 75:258-259.
6. Coutinho E., Harrison P., Vincent A. Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective. Biol. Psychiatry 2014, 75:269-275.
7. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 2001, 7:1189-1193.
8. Dickerson F., Stallings C., Vaughan C., Origoni A., Khushalani S., Yolken R. Antibodies to the glutamate receptor in mania. Bipolar Disord. 2012, 14:547-553.
9. Drexhage R.C., Weigelt K., van Beveren N., Cohen D., Versnel M.A., Nolen W.A., Drexhage H.A. Immune and neuroimmune alterations in mood disorders and schizophrenia. Int. Rev. Neurobiol. 2011, 101:169-201.
10. Ezeoke A., Mellor A., Buckley P., Miller B. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr. Res. 2013, 150:245-251.
11. Fragoso-Loyo H., Cabiedes J., Orozco-Narvaez A., Davila-Maldonado L., Atisha-Fregoso Y., Diamond B., Llorente L., Sanchez-Guerrero J. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLos One 2008, 3:e3347.
12. Gupta D., Radhakrishnan M., Bhatt S., Kurhe Y. Role of hypothalamic-pituitary-adrenal-axis in affective disorders: anti-depressant and anxiolytic activity of partial 5-HT1A agonist in adrenalectomised rats. Indian J. Psychol. Med. 2013, 35:290-298.
13. Haussleiter I.S., Emons B., Schaub M., Borowski K., Brune M., Wandinger K.P., Juckel G. Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients. Schizophr. Res. 2012, 140:258-259.
14. Jones A.L., Mowry B.J., Pender M.P., Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunol. Cell. Biol. 2005, 83:9-17.
15. Kayser M.S., Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr. Res. 2014, 10.1016/j.schres.2014.10.007.
16. Laske C., Zank M., Klein R., Stransky E., Batra A., Buchkremer G., Schott K. Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls. Psychiatry Res. 2008, 158:83-86.
17. Lauvsnes M.B., Omdal R. Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J. Neurol. 2012, 259:622-629.
18. Margari F., Petruzzelli M.G., Mianulli R., Toto M., Pastore A., Bizzaro N., Tampoia M. Anti-brain autoantibodies in the serum of schizophrenic patients: a case-control study. Psychiatry Res. 2013, 210:800-805.
19. Martinez-Martinez P., Molenaar P.C., Losen M., Stevens J., Baets M.H., Szoke A., Honnorat J., Tamouza R., Leboyer M., Os J.V., Rutten B.P. Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders. Front. Genet. 2013, 4:181.
20. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
21. Padmos R.C., Bekris L., Knijff E.M., Tiemeier H., Kupka R.W., Cohen D., Nolen W.A., Lernmark A., Drexhage H.A. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol. Psychiatry 2004, 56:476-482.
22. Pathmanandavel K., Starling J., Dale R.C., Brilot F. Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives. Clin. Dev. Immunol. 2013, 2013:257184.
23. Pearlson G.D. Etiologic, phenomenologic, and endophenotypic overlap of schizophrenia and bipolar disorder. Annu. Rev. Clin. Psychol. 2015, 11:251-281.
24. Postal M., Costallat L.T., Appenzeller S. Biological therapy in systemic lupus erythematosus. Int. J. rheumatol. 2012, 2012:578641.
25. Rhoads J., Guirgis H., McKnight C., Duchemin A.M. Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophr. Res. 2011, 129:213-214.
26. Rice J.S., Kowal C., Volpe B.T., DeGiorgio L.A., Diamond B. Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. Curr. Top. microbiol. immunol. 2005, 296:137-151.
27. Rivollier F., Lotersztajn L., Chaumette B., Krebs M.O., Kebir O. Epigenetics of schizophrenia: a review. L'Encepha 2014, 40:380-386.
28. Rosenblat J.D., Cha D.S., Mansur R.B., McIntyre R.S. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuro -Psychopharmacol. Biol. Psychiatry 2014, 53:23-34.
29. Sidhom O., Laadhar L., Zitouni M., Ben Alaya N., Rafrafi R., Kallel-Sellami M., Lahmar H., El Hechmi Z., Makni S. Spectrum of autoantibodies in Tunisian psychiatric inpatients. Immunol. Investig. 2012, 41:538-549.
30. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr. Res. 2014, 10.1016/j.schres.2014.06.027.
31. Smyth A.M., Lawrie S.M. The neuroimmunology of schizophrenia. Clin. psychopharmacol. Neurosci.: Off. Sci. J. Korean Coll. Neuropsychopharmacol. 2013, 11:107-117.
32. Steiner J., Walter M., Glanz W., Sarnyai Z., Bernstein H.G., Vielhaber S., Kastner A., Skalej M., Jordan W., Schiltz K., Klingbeil C., Wandinger K.P., Bogerts B., Stoecker W. Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013, 70:271-278.
33. Titulaer M.J., Dalmau J. Antibodies to NMDA receptor, blood-brain barrier disruption and schizophrenia: a theory with unproven links. Mol. Psychiatry 2014, 19:1054.
34. Toto M., Margari F., Simone M., Craig F., Petruzzelli M.G., Tafuri S., Margari L. Antibasal ganglia antibodies and antistreptolysin O in noncomorbid ADHD. J. Atten. disord. 2012.
35. Uher R. Gene-environment interactions in severe mental illness. Front. Psychiatry 2014, 5:48.
36. Vreeburg S.A., Hoogendijk W.J., van Pelt J., Derijk R.H., Verhagen J.C., van Dyck R., Smit J.H., Zitman F.G., Penninx B.W. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch. Gen. Psychiatry 2009, 66:617-626.